196 related articles for article (PubMed ID: 7533000)
1. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.
Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H
Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000
[TBL] [Abstract][Full Text] [Related]
2. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
3. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
[TBL] [Abstract][Full Text] [Related]
4. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
5. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
EXS; 1997; 79():233-69. PubMed ID: 9002222
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
Detmar M; Yeo KT; Nagy JA; Van de Water L; Brown LF; Berse B; Elicker BM; Ledbetter S; Dvorak HF
J Invest Dermatol; 1995 Jul; 105(1):44-50. PubMed ID: 7615975
[TBL] [Abstract][Full Text] [Related]
7. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
Zeng H; Sanyal S; Mukhopadhyay D
J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426
[TBL] [Abstract][Full Text] [Related]
9. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.
Sundberg C; Nagy JA; Brown LF; Feng D; Eckelhoefer IA; Manseau EJ; Dvorak AM; Dvorak HF
Am J Pathol; 2001 Mar; 158(3):1145-60. PubMed ID: 11238063
[TBL] [Abstract][Full Text] [Related]
10. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
Basu S; Nagy JA; Pal S; Vasile E; Eckelhoefer IA; Bliss VS; Manseau EJ; Dasgupta PS; Dvorak HF; Mukhopadhyay D
Nat Med; 2001 May; 7(5):569-74. PubMed ID: 11329058
[TBL] [Abstract][Full Text] [Related]
11. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
12. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
[TBL] [Abstract][Full Text] [Related]
14. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.
Banerjee SK; Sarkar DK; Weston AP; De A; Campbell DR
Carcinogenesis; 1997 Jun; 18(6):1155-61. PubMed ID: 9214597
[TBL] [Abstract][Full Text] [Related]
15. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121).
Asano M; Yukita A; Matsumoto T; Matsuo K; Kondo S; Suzuki H
Hybridoma; 1995 Oct; 14(5):475-80. PubMed ID: 8575796
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.
Detmar M; Brown LF; Berse B; Jackman RW; Elicker BM; Dvorak HF; Claffey KP
J Invest Dermatol; 1997 Mar; 108(3):263-8. PubMed ID: 9036922
[TBL] [Abstract][Full Text] [Related]
18. Expression of biologically active human vascular endothelial growth factor in yeast.
Mohanraj D; Olson T; Ramakrishnan S
Growth Factors; 1995; 12(1):17-27. PubMed ID: 8527160
[TBL] [Abstract][Full Text] [Related]
19. Vascular permeability factor (VPF, VEGF) in tumor biology.
Senger DR; Van de Water L; Brown LF; Nagy JA; Yeo KT; Yeo TK; Berse B; Jackman RW; Dvorak AM; Dvorak HF
Cancer Metastasis Rev; 1993 Sep; 12(3-4):303-24. PubMed ID: 8281615
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
